Cargando…
Soluble plasma proteins ST2 and CD163 as early biomarkers of nephropathy in Swedish patients with diabetes, 15–34 years of age: a prospective cohort study
BACKGROUND: The aim of this study was to investigate plasma levels of sST2 and sCD163 to determine whether they at an early stage could predict development of diabetic nephropathy and/or diabetic retinopathy in patients at clinical onset. METHODS: Patients diagnosed with diabetes mellitus at age 15–...
Autores principales: | Samuelsson, My, Dereke, Jonatan, Svensson, Maria K., Landin-Olsson, Mona, Hillman, Magnus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445394/ https://www.ncbi.nlm.nih.gov/pubmed/28559931 http://dx.doi.org/10.1186/s13098-017-0240-2 |
Ejemplares similares
-
Soluble CD163 and TWEAK in early pregnancy gestational diabetes and later glucose intolerance
por: Dereke, Jonatan, et al.
Publicado: (2019) -
Soluble CD163 was linked to galectin-3, diabetic retinopathy and antidepressants in type 1 diabetes
por: Melin, Eva O, et al.
Publicado: (2018) -
Female sex, high soluble CD163, and low HDL-cholesterol were associated with high galectin-3 binding protein in type 1 diabetes
por: Melin, Eva Olga, et al.
Publicado: (2019) -
Soluble CD163 and glycated haemoglobin were independently associated with the progression of diabetic retinopathy in adult patients with type 1 diabetes
por: Hector, Sven, et al.
Publicado: (2023) -
Low levels of soluble TWEAK, indicating on-going inflammation, were associated with depression in type 1 diabetes: a cross-sectional study
por: Melin, Eva O., et al.
Publicado: (2020)